Immunotherapy of Stage III/IV Melanoma Patients

NCT00112242 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
39
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Centre Hospitalier Universitaire Vaudois

Collaborators